Our data indicated a pro-tumoral role of OTUD6B, which was inconsistent with the previous survivorship curve, indicating that OTUD6B exerts an antitumor effect on colorectal cancer in patients with CRC (Fig. 1G). The gene discussed is OTUD6B; the disease is colorectal carcinoma.